Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021.
Bourbeau B, Lyman GH, Lei XJ, Jones L, Rosenthal J, Kozlik MM, Oettel KR, Tinger A, Page R. Bourbeau B, et al. Among authors: lyman gh. JCO Oncol Pract. 2023 Jul;19(7):516-522. doi: 10.1200/OP.22.00618. Epub 2023 Apr 21. JCO Oncol Pract. 2023. PMID: 37084324
Oncology Clinical Pathways: Charting the Landscape of Pathway Providers.
Daly B, Zon RT, Page RD, Edge SB, Lyman GH, Green SR, Wollins DS, Bosserman LD. Daly B, et al. Among authors: lyman gh. J Oncol Pract. 2018 Mar;14(3):e194-e200. doi: 10.1200/JOP.17.00033. Epub 2018 Feb 7. J Oncol Pract. 2018. PMID: 29412768 No abstract available.
Use of Biosimilar Medications in Oncology.
Nahleh Z, Lyman GH, Schilsky RL, Peterson DE, Tagawa ST, Chavez-MacGregor M, Rumble RB, Gupta S. Nahleh Z, et al. Among authors: lyman gh. JCO Oncol Pract. 2022 Mar;18(3):177-186. doi: 10.1200/OP.21.00771. Epub 2022 Jan 18. JCO Oncol Pract. 2022. PMID: 35041524 Review.
570 results